Research programs

Research Research programs

The compass of our research efforts

Our research programs provide inspiring environments where researchers work towards a common goal, across thematic and disciplinary borders.

Our 52 research programs

3D biology and disease mechanisms

This program aims to identify mechanisms of therapy resistance in model systems.

Academic drug therapy development: pharmacological interventions to optimize the risk-benefit-ratio for patients and sustainable drug use

This program aims to develop novel pharmacotherapeutic treatment strategies and technologies, from a societal perspective.

Amalia P4 research program

This program aims to further improve the entire spectrum of prevention, diagnostics, therapy, care and innovation in all stages from preconception, pregnancy, and childhood to transition into adulthood.

Atherosclerosis & thrombosis

This program aims to impove personalized risk prediction, prevention, early detection, diagnosis, and treatment of atherosclerotic and thrombotic cardiovascular diseases.

Biomarker discovery and implementation: a sine qua non for improvement of personalized health interventions

This program aims to understand and translate insights in mechanisms of disease into robust and innovative biomarkers to support health and healthcare.

Breast cancer

This program aims to gather and integrate information on each individual woman’s and the pathology’s characteristics to optimize the entire pathway of breast cancer care.

Cancer immunotherapy: a pan-cancer program

This program aims to unravel the underlying mechanisms of tumor-immune attack and resistance in a wide variety of cancer types and contribute to better clinical outcomes of cancer patients treated with immunotherapy.

Cellular adaptive immunity

This program aims to develop and continuously update technical expertise to analyse cellular adaptive immunity and update, develop and standardize tools and computational analyses and modelling of the data across disease fields.